Annual Accounts Payable
$11.48 M
+$5.08 M+79.38%
November 30, 2024
Summary
- As of February 7, 2025, NRIX annual accounts payable is $11.48 million, with the most recent change of +$5.08 million (+79.38%) on November 30, 2024.
- During the last 3 years, NRIX annual accounts payable has risen by +$4.83 million (+72.66%).
- NRIX annual accounts payable is now at all-time high.
Performance
NRIX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$11.48 M
+$7.56 M+193.06%
November 30, 2024
Summary
- As of February 7, 2025, NRIX quarterly accounts payable is $11.48 million, with the most recent change of +$7.56 million (+193.06%) on November 30, 2024.
- Over the past year, NRIX quarterly accounts payable has increased by +$5.56 million (+94.02%).
- NRIX quarterly accounts payable is now at all-time high.
Performance
NRIX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NRIX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +79.4% | +94.0% |
| 3 y3 years | +72.7% | +104.0% |
| 5 y5 years | +618.5% | +104.0% |
NRIX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +126.7% | at high | +425.0% |
| 5 y | 5-year | at high | +618.5% | at high | +618.5% |
| alltime | all time | at high | +785.3% | at high | +618.5% |
Nurix Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | $11.48 M(+79.4%) | $11.48 M(+193.1%) |
| Aug 2024 | - | $3.92 M(+39.3%) |
| May 2024 | - | $2.81 M(-52.5%) |
| Feb 2024 | - | $5.92 M(-7.5%) |
| Nov 2023 | $6.40 M(+26.4%) | $6.40 M(+192.7%) |
| Aug 2023 | - | $2.19 M(-51.7%) |
| May 2023 | - | $4.53 M(-19.6%) |
| Feb 2023 | - | $5.63 M(+11.2%) |
| Nov 2022 | $5.06 M | $5.06 M(-16.3%) |
| Aug 2022 | - | $6.05 M(-1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| May 2022 | - | $6.14 M(+2.1%) |
| Feb 2022 | - | $6.01 M(-9.6%) |
| Nov 2021 | $6.65 M(+94.9%) | $6.65 M(+72.2%) |
| Aug 2021 | - | $3.86 M(-28.6%) |
| May 2021 | - | $5.41 M(+23.2%) |
| Feb 2021 | - | $4.39 M(+28.6%) |
| Nov 2020 | $3.41 M(+113.5%) | $3.41 M(-5.5%) |
| Aug 2020 | - | $3.61 M(-26.4%) |
| May 2020 | - | $4.90 M(+206.8%) |
| Nov 2019 | $1.60 M(+23.2%) | $1.60 M |
| Nov 2018 | $1.30 M | - |
FAQ
- What is Nurix Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Nurix Therapeutics?
- What is Nurix Therapeutics annual accounts payable year-on-year change?
- What is Nurix Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Nurix Therapeutics?
- What is Nurix Therapeutics quarterly accounts payable year-on-year change?
What is Nurix Therapeutics annual accounts payable?
The current annual accounts payable of NRIX is $11.48 M
What is the all time high annual accounts payable for Nurix Therapeutics?
Nurix Therapeutics all-time high annual accounts payable is $11.48 M
What is Nurix Therapeutics annual accounts payable year-on-year change?
Over the past year, NRIX annual accounts payable has changed by +$5.08 M (+79.38%)
What is Nurix Therapeutics quarterly accounts payable?
The current quarterly accounts payable of NRIX is $11.48 M
What is the all time high quarterly accounts payable for Nurix Therapeutics?
Nurix Therapeutics all-time high quarterly accounts payable is $11.48 M
What is Nurix Therapeutics quarterly accounts payable year-on-year change?
Over the past year, NRIX quarterly accounts payable has changed by +$5.56 M (+94.02%)